MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clinme.2026.100577

Медицинская библиотека · Clinical medicine (London, England) · 2026

Renin-angiotensin system inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heart.

Murray Jonathan S, Kalra Paul R, Anderson Lisa J, Selby Nicholas M, Sawhney Simon, McKane William S, Ostermann Marlies, Kolhe Nitin V, McWilliam Stephen J, Nagalingam Karen, Bickerton Shelagh, Lewington Andrew J P, Hinchliffe William T, Smith Simon J, Wise Michael, Hancock Alan, Kingdon Edward, Cockwell Paul, James Matthew T, Blakeman Thomas, Dean John D, Morlidge Clare, Tomlinson Laurie A, Green Darren

СтатьяОбзорПеревод в очереди

Аннотация

Healthcare professionals should not label medications as 'kidney toxins' unless this is actually the case, especially medications that instead confer clear prognostic benefit, such as renin-angiotensin system inhibitors (RASi). This is imperative when discussing treatments with people with long-term health conditions, for whom RASi significantly reduce death, progression of chronic kidney disease (CKD) and hospitalisation. RASi are fundamental to management of heart failure with reduced ejection fraction (HFrEF) and CKD with proteinuria, yet are frequently called 'nephrotoxic'. The association between RASi use and acute kidney injury (AKI) is too often mistaken for 'causation'; it is largely driven by the use of RASi to treat long-term conditions that increase AKI risk, such as HFrEF, CKD and diabetes mellitus. Mislabelling RASi as 'nephrotoxic' adversely affects vital decision making, driving a tendency for RASi avoidance, even when RASi use has clear prognostic benefit. Healthcare education must embed this clinically important change to convention.

Для цитирования: Murray Jonathan S, Kalra Paul R, Anderson Lisa J, Selby Nicholas M, Sawhney Simon, McKane William S, Ostermann Marlies, Kolhe Nitin V, McWilliam Stephen J, Nagalingam Karen, Bickerton Shelagh, Lewington Andrew J P, Hinchliffe William T, Smith Simon J, Wise Michael, Hancock Alan, Kingdon Edward, Cockwell Paul, James Matthew T, Blakeman Thomas, Dean John D, Morlidge Clare, Tomlinson Laurie A, Green Darren. Renin-angiotensin system inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heart.. Clinical medicine (London, England). 2026. DOI: 10.1016/j.clinme.2026.100577.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.